These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11331019)

  • 1. Hypersensitization of tumor cells to glycolytic inhibitors.
    Liu H; Hu YP; Savaraj N; Priebe W; Lampidis TJ
    Biochemistry; 2001 May; 40(18):5542-7. PubMed ID: 11331019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C).
    Liu H; Savaraj N; Priebe W; Lampidis TJ
    Biochem Pharmacol; 2002 Dec; 64(12):1745-51. PubMed ID: 12445863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
    Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
    Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
    Goetze K; Fabian CG; Siebers A; Binz L; Faber D; Indraccolo S; Nardo G; Sattler UG; Mueller-Klieser W
    Cell Oncol (Dordr); 2015 Oct; 38(5):377-85. PubMed ID: 26288178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
    Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J
    J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose deprivation produces a prolonged increase in sensitivity to glutamate in cultured rat cortical neurons.
    Vergun O; Han YY; Reynolds IJ
    Exp Neurol; 2003 Oct; 183(2):682-94. PubMed ID: 14552910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
    Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
    Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of tumour glucose metabolism for therapeutic benefit.
    Hamilton E; Fennell M; Stafford DM
    Acta Oncol; 1995; 34(3):429-33. PubMed ID: 7779436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant increase of glycolytic flux in Torulopsis glabrata by inhibition of oxidative phosphorylation.
    Liu L; Li Y; Li H; Chen J
    FEMS Yeast Res; 2006 Dec; 6(8):1117-29. PubMed ID: 16972982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
    Maschek G; Savaraj N; Priebe W; Braunschweiger P; Hamilton K; Tidmarsh GF; De Young LR; Lampidis TJ
    Cancer Res; 2004 Jan; 64(1):31-4. PubMed ID: 14729604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolysis as primary energy source in tumor cell chemotaxis.
    Beckner ME; Stracke ML; Liotta LA; Schiffmann E
    J Natl Cancer Inst; 1990 Dec; 82(23):1836-40. PubMed ID: 2174462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.
    Maher JC; Krishan A; Lampidis TJ
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):116-22. PubMed ID: 14605866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential.
    Contreras-Lopez R; Elizondo-Vega R; Luque-Campos N; Torres MJ; Pradenas C; Tejedor G; Paredes-Martínez MJ; Vega-Letter AM; Campos-Mora M; Rigual-Gonzalez Y; Oyarce K; Salgado M; Jorgensen C; Khoury M; Garcia-Robles MLÁ; Altamirano C; Djouad F; Luz-Crawford P
    Theranostics; 2021; 11(1):445-460. PubMed ID: 33391485
    [No Abstract]   [Full Text] [Related]  

  • 15. Impairment of mitochondrial respiration in mouse fibroblasts by oncogenic H-RAS(Q61L).
    Yang D; Wang MT; Tang Y; Chen Y; Jiang H; Jones TT; Rao K; Brewer GJ; Singh KK; Nie D
    Cancer Biol Ther; 2010 Jan; 9(2):122-33. PubMed ID: 19923925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
    Fiume L; Manerba M; Vettraino M; Di Stefano G
    Pharmacology; 2010; 86(3):157-62. PubMed ID: 20699632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes.
    Dietl K; Renner K; Dettmer K; Timischl B; Eberhart K; Dorn C; Hellerbrand C; Kastenberger M; Kunz-Schughart LA; Oefner PJ; Andreesen R; Gottfried E; Kreutz MP
    J Immunol; 2010 Feb; 184(3):1200-9. PubMed ID: 20026743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae.
    Rasmussen AK; Chatterjee A; Rasmussen LJ; Singh KK
    Nucleic Acids Res; 2003 Jul; 31(14):3909-17. PubMed ID: 12853606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modulation of action potential generation by calcium-induced calcium release is enhanced by mitochondrial inhibitors in mudpuppy parasympathetic neurons.
    Barstow KL; Locknar SA; Merriam LA; Parsons RL
    Neuroscience; 2004; 124(2):327-39. PubMed ID: 14980383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants.
    Marroquin LD; Hynes J; Dykens JA; Jamieson JD; Will Y
    Toxicol Sci; 2007 Jun; 97(2):539-47. PubMed ID: 17361016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.